The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth
Open Access
- 15 February 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (6), 536-537
- https://doi.org/10.1093/eurheartj/ehi155
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamilJournal of the American College of Cardiology, 2005
- Anti-HERG activity and the risk of drug-induced arrhythmias and sudden deathEuropean Heart Journal, 2005
- Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic PropertiesCirculation, 2004
- Drug‐Induced Torsades de Pointes and Implications for Drug DevelopmentJournal of Cardiovascular Electrophysiology, 2004
- Torsade de Pointes Due to Noncardiac DrugsMedicine, 2003
- Long QT syndrome caused by noncardiac drugsProgress in Cardiovascular Diseases, 2003
- Comparison of the In Vivo Electrophysiological and Proarrhythmic Effects of Amiodarone With Those of a Selective Class III Drug, Sematilide, Using a Canine Chronic Atrioventricular Block Model.Circulation Journal, 2002
- A structural basis for drug-induced long QT syndromeProceedings of the National Academy of Sciences of the United States of America, 2000
- Long QT syndromes and torsade de pointesThe Lancet, 1999